XML 69 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT AND GEOGRAPHIC INFORMATION
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SEGMENT AND GEOGRAPHIC INFORMATION SEGMENT AND GEOGRAPHIC INFORMATION
The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.
•The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
•The Tissue Technologies segment includes such offerings as skin and wound repair, plastics & surgical reconstruction products, bone grafts, and nerve and tendon repair products.
The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.
The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December 31, 2023, 2022 and 2021 are as follows:
 Years Ended December 31,
Dollars in thousands202320222021
Segment Net Sales
Codman Specialty Surgical$1,058,993 $1,019,564 $1,025,232 
 Tissue Technologies482,580 538,102 517,216 
Total revenues$1,541,573 $1,557,666 $1,542,448 
Segment Profit
Codman Specialty Surgical$450,530 $417,873 $439,471 
Tissue Technologies134,048 233,802 228,199 
Segment profit584,578 651,675 667,670 
Amortization(12,376)(13,882)(16,914)
Corporate and other(460,676)(398,873)(453,526)
Operating income$111,526 $238,920 $197,230 
The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:
Dollars in thousands
United States(1)
EuropeAsia PacificRest of the WorldConsolidated
Total revenue, net:
2023$1,100,730 $165,221 $193,096 $82,526 $1,541,573 
20221,126,810 170,903 176,477 83,476 1,557,666 
20211,089,526 191,327 182,034 79,561 1,542,448 
Total long-lived assets:
2023$481,508 $51,730 $19,842 $1,497 $554,577 
2022440,223 60,857 12,975 2,721 516,776